Evidence map›Paper›PMID 39845198›Full record

ArticleInternational medical case reports journal2025

X-Linked Autism Type 9 Caused by a Hemizygote Pathogenic Variant in the

Willem M A Verhoeven, Rolph Pfundt, Udo F H Engelke, Leo A J Kluijtmans, Jos I M Egger

Abstract readCase Reports
In one paragraph

Article in International medical case reports journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Willem M A VerhoevenDepartment of Psychiatry, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0001-9363-1116
Rolph PfundtDepartment of Human Genetics, Radboud University Medical Centre, Nijmegen, The Netherlands.ORCID 0000-0002-0584-4398
Udo F H EngelkeDepartment of Human Genetics, Translational Metabolic Laboratory, Radboud University Medical Centre, Nijmegen, The Netherlands.ORCID 0000-0002-0980-238X
Leo A J KluijtmansDepartment of Human Genetics, Translational Metabolic Laboratory, Radboud University Medical Centre, Nijmegen, The Netherlands.ORCID 0000-0002-1999-3378
Jos I M EggerVincent van Gogh Centre of Excellence for Neuropsychiatry, Venray, The Netherlands.ORCID 0000-0002-9311-9013

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Levocarnitine is essential for brain functioning and fatty acid metabolism and stems largely from dietary sources. The Epsilon-Trimethyllysine Hydroxylase ( Patient and Methods: Here, an institutionalized adult male patient with intellectual disability, autism, and challenging behaviours is presented in whom genetic analysis disclosed a novel pathogenic variant in the Results: Moderate intellectual disability along with obsessive and aggressive behaviour in the context of autism spectrum disorders was established as well as symptoms from the catatonic spectrum. With WES, a novel variant in the Conclusion: X-linked autism type 6 is characterized by moderate intellectual disability and symptoms from the autism spectrum in the absence of any dysmorphisms. To prevent regressive autistic episodes in young children, it is highly recommended to consider next-generation sequencing techniques as the first step in the differential diagnostic process of autism.

Indexed as

autismcontextual neuropsychologyepsilon-trimethyllysine hydroxylase geneintellectual disabilitylevocarnitinepsychopathologyTMLHE

Identifiers

PMID39845198
PMCPMC11753900

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.